Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Kedoya Adyaraya Tbk. (RSGK) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Kedoya Adyaraya Tbk.Trade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Kedoya Adyaraya Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 308B, 27.5K 24h volume), while Kedoya Adyaraya Tbk. trades at Rp1,050 (market cap 976.16B, 2.1K 24h volume). The key difference: Kedoya Adyaraya Tbk. is far larger — about 3.2× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (27.5K versus 2.1K). Which is the better fit depends on your goals.

DGNSRSGK
Market Cap
308B976.16B
Volume
27.5K2.1K
Lot
27521
Turnover
6.23M2.21M
Average Price
226.591,050
Value
6.23M2.21M
Indicative Equilibrium Price
2301,050
Indicative Equilibrium Volume
110900

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
RSGK
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Kedoya Adyaraya Tbk.

PT Kedoya Adyaraya Tbk (the Company) was established on June 11, 1990 based on Notarial Deed No. 104 of Darsono Purnomosidi, S.H., Notary in Jakarta. The Company started its commercial operations in 2011. PT Medikatama Sejahtera is the ultimate parent Company of the Company and its Subsidiaries.

Read more on RSGK